Aug 23, 2024 / 11:30AM GMT
Per Plotnikof - ALK-Abello A/S-Vice President-Corporate Communications - Investor Relations and Strategic Planning
Hello, everyone, and welcome to this presentation on the ALK's Q2 results. Thank you, all for joining us. And let's turn to slide number 2, with an intro to the agenda and the speakers. My name is Per Plotnikof. I'm Head of Investor Relations. With me today are CEO, Peter Halling; and CFO, Claus Steensen Solje.
We'll first share a couple of highlights from the quarter and then, we will take a closer look at the markets, product trends and financials. We'll also provide an update on the Allergy-plus strategy implementation before we cover the full year outlook. As usual, we will end the presentation with a Q&A session.
And to get started, I'll now hand you over to Peter and slide number 3.
Peter Halling - ALK-Abello A/S-President - Chief Executive Officer
Thank you, Per, and thank you all for joining this call. The current
Q2 2024 ALK-Abello A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot